Search research articles
Contact Us
Filters
Showing results (21-30 of 73) with videos related to
Page
of 8
Sort By:
Journal of Geriatric Oncology
|
July 21, 2023
Risk of cancer-specific death among octogenarians with multiple myeloma: A population-based analysis
Joanne Britto, Hsien Seow, Gregory R Pond, et al.
Blood Cancer Journal
|
April 27, 2023
An atlas of the bone marrow bone proteome in patients with dysproteinemias
Matthew Ho, Surendra Dasari, Alissa Visram, et al.
Leukemia & Lymphoma
|
April 16, 2024
Prevalence of geriatric impairments and frailty categorization among real-world patients with multiple myeloma: a prospective cohort study (MFRAIL)
Imran Haider, Darryl P Leong, Martha Louzada, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 20, 2024
First Line Treatment of Newly Diagnosed Transplant Eligible Multiple Myeloma Recommendations From a Canadian Consensus Guideline Consortium
Sahar Khan, Debra J Bergstrom, Julie Côté, et al.
Blood Cancer Journal
|
March 27, 2026
Impact of clinical surveillance on myeloma-related complications in patients with precursor plasma cell disorders
Edward Koo, Sarah Albert, Benjamin Patrick, et al.
Blood Cancer Journal
|
October 14, 2024
Patterns of progression in a contemporary cohort of 447 patients with smoldering multiple myeloma
Annika Werly, Mareike Hampel, Thomas Hielscher, et al.
Cancer Letters
|
December 26, 2025
Anti-BCMA-CAR-IL15 natural killer cells prevent multiple myeloma growth in the bone marrow but allow subsequent emergence of extramedullary disease
Shelby Kaczmarek, Donghyeon Jo, Safa Ghaziasgar, et al.
Frontiers in Immunology
|
March 24, 2025
Entinostat, a histone deacetylase inhibitor, enhances CAR-NK cell anti-tumor activity by sustaining CAR expression
Dong-Hyeon Jo, Shelby Kaczmarek, Abrar Ul Haq Khan, et al.
Cytotherapy
|
December 18, 2024
Efficacy of chimeric antigen receptor engineered natural killer cells in the treatment of hematologic malignancies: a systematic review and meta-analysis of preclinical studies
Donald J Bastin, Marisa K Kilgour, Risa Shorr, et al.
The Oncologist
|
April 18, 2024
A Prognostic Survival Model Incorporating Patient-Reported Outcomes for Transplant-Ineligible Patients With Multiple Myeloma
Hira Mian, Hsien Seow, Amaris K Balitsky, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 73) with videos related to
Sort By:
Page
of 8
Journal of Geriatric Oncology
|
July 21, 2023
Risk of cancer-specific death among octogenarians with multiple myeloma: A population-based analysis
Joanne Britto, Hsien Seow, Gregory R Pond, et al.
Blood Cancer Journal
|
April 27, 2023
An atlas of the bone marrow bone proteome in patients with dysproteinemias
Matthew Ho, Surendra Dasari, Alissa Visram, et al.
Leukemia & Lymphoma
|
April 16, 2024
Prevalence of geriatric impairments and frailty categorization among real-world patients with multiple myeloma: a prospective cohort study (MFRAIL)
Imran Haider, Darryl P Leong, Martha Louzada, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 20, 2024
First Line Treatment of Newly Diagnosed Transplant Eligible Multiple Myeloma Recommendations From a Canadian Consensus Guideline Consortium
Sahar Khan, Debra J Bergstrom, Julie Côté, et al.
Blood Cancer Journal
|
March 27, 2026
Impact of clinical surveillance on myeloma-related complications in patients with precursor plasma cell disorders
Edward Koo, Sarah Albert, Benjamin Patrick, et al.
Blood Cancer Journal
|
October 14, 2024
Patterns of progression in a contemporary cohort of 447 patients with smoldering multiple myeloma
Annika Werly, Mareike Hampel, Thomas Hielscher, et al.
Cancer Letters
|
December 26, 2025
Anti-BCMA-CAR-IL15 natural killer cells prevent multiple myeloma growth in the bone marrow but allow subsequent emergence of extramedullary disease
Shelby Kaczmarek, Donghyeon Jo, Safa Ghaziasgar, et al.
Frontiers in Immunology
|
March 24, 2025
Entinostat, a histone deacetylase inhibitor, enhances CAR-NK cell anti-tumor activity by sustaining CAR expression
Dong-Hyeon Jo, Shelby Kaczmarek, Abrar Ul Haq Khan, et al.
Cytotherapy
|
December 18, 2024
Efficacy of chimeric antigen receptor engineered natural killer cells in the treatment of hematologic malignancies: a systematic review and meta-analysis of preclinical studies
Donald J Bastin, Marisa K Kilgour, Risa Shorr, et al.
The Oncologist
|
April 18, 2024
A Prognostic Survival Model Incorporating Patient-Reported Outcomes for Transplant-Ineligible Patients With Multiple Myeloma
Hira Mian, Hsien Seow, Amaris K Balitsky, et al.
Page
of 8